Clinical Trials Directory

Trials / Completed

CompletedNCT05603130

Epidemiologic Register on Diabetes and COVID-19 in Tunisia

Diabetes and COVID-19 in Tunisia (CoviDTUN)

Status
Completed
Phase
Study type
Observational
Enrollment
811 (actual)
Sponsor
Les Laboratoires des Médicaments Stériles · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

CoviDTUN is a multicenter observatory set up by a steering committee to determine the presentation and evolution of diabetes in COVID-19 and study its pathogenesis. The observatory comprises a dataset consisting of routinely collected clinical information anonymously to be entered by the investigator as a participating clinician/researcher. The study will be an opportunity to understand the relationship between COVID-19 and diabetes, to enrich Tunisian data on diabetic and de novo diabetic patients who have contracted COVID-19 and to evaluate the prognostic severity factors for better management of these patients.

Detailed description

It is a multicentric Tunisian observatory for COVID-19 patients. Confirmed COVID-19 patients, treated on an outpatient basis, in containment centers or hospitalized in COVID-19 units were included retrospectively from March 2020 and had continued prospectively til June 2022. The study had selected eligible patient recorded for inclusion by free practice physicians and hospital physicians. General data, medical history, epidemiological characteristics, clinical examination, biological assessment (blood glucose, NFS, CRP, D-dimer, etc.), clinical course and complications were therefore recorded in a structured and anonymized database. Data collection was carried out by DACIMA Clinical Suite® solution, in accordance with the normative and regulatory provisions in force in the management of health data.

Conditions

Interventions

TypeNameDescription
OTHERroutinely collected clinical informationmedical history, epidemiological characteristics, clinical examination, biological assessment (blood glucose, NFS, CRP, D-dimer,etc...)

Timeline

Start date
2022-03-23
Primary completion
2022-06-30
Completion
2022-10-17
First posted
2022-11-02
Last updated
2022-11-02

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT05603130. Inclusion in this directory is not an endorsement.